Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Solid Tumor × Off-Label Use × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumor 1 Nasopharyngeal Carcinoma 1

Interventions

Injections 5 Fluorodeoxyglucose F18 4 Bevacizumab 4 Cyclophosphamide 3 toripalimab 2 fludarabine 2 Nivolumab 2 zimberelimab 1 tumor-cells apoptosis factor, human 1 trametinib 1 tislelizumab 1 temsirolimus 1 spartalizumab 1 pembrolizumab 1 pazopanib 1 palbociclib 1 olaparib 1 lenvatinib 1 enzalutamide 1 donafenib 1 disitamab vedotin 1 dabrafenib 1 cemiplimab 1 avelumab 1 atezolizumab 1 anlotinib 1 WW Domain-Containing Oxidoreductase 1 Valproic Acid 1 Ultrasonography, Doppler 1 Ultrasonography 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06956248 2025-05-04

IMPACT-INSPIRE

National Cancer Centre, Singapore

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡